Dentons continues to strengthen its IP and Life Sciences offering for clients in Australia with the appointment of Managing Associate James Ellsmore. Formerly with King & Wood Mallesons LLP, James has ten years’ experience as an IP litigation lawyer with a focus on patents and life sciences. His practice also includes general commercial litigation, commercialisation and health/pharma regulatory advice.
James acts for a broad range of clients on IP and general commercial law, licensing disputes, comparative advertising and misleading and deceptive conduct, misuse of confidential information, copyright infringement and general contractual disputes. James also advises on the regulation of pharmaceuticals and medical devices in Australia, and has acted for clients in patent litigation in the High Court of Australia, Federal Court of Australia and before the Commissioner of Patents.
James has been recognised as a Next Generation lawyer for IP by the Legal500 Asia Pacific for 2018 and 2019, and was also listed this month in DOYLES’ list of Intellectual Property & TMT Rising Stars Australia, 2019.
Dentons’ Australia Region Chair and CEO Doug Stipanicev said James’ appointment is another important step in growing the IP and Life Sciences capability of the Firm in Australia.
“James brings a wealth of experience to the team and I’m delighted to welcome him to the Firm. Dentons already has a very strong IP practice in Australia. Having James join the Sydney further enhances our integrated, national solution.”
Commenting on his appointment, James said: “I’m looking forward to being part of such a highly regarded IP team and connecting clients to all the opportunities the world’s largest law firm can provide.”
Source: www.dentons.com
